Skip to main content

Marex Group plc

Position in NVO — Novo Nordisk A S

CIK 1997464 London, X0

Position in NVO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$24,846,630
-$1,007,030 QoQ
Shares Held
518,286
-26.3% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#85
of 1,348 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NVO Over Time

Shares Held

Position Value (USD)

Derivatives in NVO

reported options exposure · as of Mar 31, 2026
CallValue
$0
CallShares
0
PutValue
$3,675,000
PutShares
100,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Marex Group plc holds $405,541,812 across 9 Drug Manufacturers - General names. NVO ranks #3 (6.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 NVO
Novo Nordisk A S
This page
518,286 $24,846,630

All Filings in NVO

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $24,846,630 518,286
2026-03-31 $3,675,000 100,000
2026-03-31 $25,853,660 703,501
2025-12-31 $51,170,677 1,005,713
2025-12-31 $7,632,000 150,000
2025-09-30 $36,054,072 649,740
2025-06-30 $12,497,175 181,066
2025-03-31 $5,012,386 72,183
2024-12-31 $4,382,459 50,947
2024-09-30 $714,420 6,000
2024-06-30 $1,828,642 12,811